Background illustration for clinical trials search

Paid Clinical Trials Minneapolis

Discover 1,005 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Minneapolis MN, Rochester MN, Marshfield WI,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Rural Smoking Cessation

for
Smoking Cessation
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 21+

Code: NCT06584929

Recruiting

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

for
AML, MDS, Acute Leukemia, Acute Myeloid Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 2 - 70+

Code: NCT07493538

Phase 2, Recruiting

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

for
Follicular Lymphoma, Marginal Zone Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06792825

Phase 2, Recruiting

American Indian Smokefree Native RCT

for
Smoking Cessation
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06544811

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Minneapolis MN, Sioux Falls SD, Fargo ND, Madison WI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

Role of Acetaldehyde in the Development of Oral Cancer

for
Alcohol-Related Carcinoma, Fanconi Anemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18 - 45

Code: NCT05973656

Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

for
Epithelial Ovarian Cancer, Ovarian Cancer,
Location: Minneapolis MN, Sioux Falls SD, Milwaukee WI,
Sponsor: Imunon

Sex: Female

Age: 18+

Code: NCT06915025

Phase 3, Recruiting

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

for
Chronic Lung Disease, Chronic Obstructive Pulmonary Disease,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 8 - 25

Code: NCT05025774

Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Minneapolis MN, Rochester MN, Sioux Falls SD, Fargo ND,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

UNTOLD Ovarian Cancer Unmet Needs Survey

for
Ovarian Cancer
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: Female

Age: 18+

Code: NCT07070726

Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

for
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT05805605

Phase 2, Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Minneapolis MN, Marshfield WI, Sioux Falls SD, Fargo ND,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

for
Myeloid Malignancy, Acute Myeloid Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06594445

Phase 1, Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Minneapolis MN, Rochester MN, Fargo ND, Madison WI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase 3, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Minneapolis MN, Rochester MN, Marshfield WI,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Minneapolis MN, Rochester MN, Marshfield WI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

for
Fanconi Anemia, Severe Aplastic Anemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 65

Code: NCT03579875

Phase 2, Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Minneapolis MN, Rochester MN, Marshfield WI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Minneapolis MN, Rochester MN, Marshfield WI,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting